american diabetes association history of pancreatitis glp-1 receptor agonist Frontiers Nutritional priorities to support GLP-1

In atherosclerotic plaque models, semaglutide reduced macrophage infiltration and suppressed the M1 inflammatory program

Noretatrutide is not an FDA-approved medication for weight loss or any other condition at the time of writing

Important safety information: Wegovy (semaglutide) and Mounjaro (tirzepatide) are prescription-only medications for managing obesity and, in the case of Mounjaro, also type 2 diabetes

In chow-fed lean mice, P5 or Ex4 dosed at 1 g kg 1 significantly increased the level of insulin compared with control mice (Fig

Clarke, G

"Finding new and better treatments is critically important to help people live healthier lives." References Nirupam M Srinivasan, Mehdi Farokhnia, Lisa A Farinelli, Anna Ferrulli, Lorenzo Leggio, GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer, Journal of the Endocrine Society , Volume 9, Issue 11, November 2025, bvaf141,